Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Madden

Showing results (451-460 of 536) with videos related to

Pageof 54
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2019
BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast CancerLouise Walsh, Kathryn E Haley, Bruce Moran, et al.
Breast Cancer Research : BCR|July 29, 2017
Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapiesSinead Toomey, Alexander J Eustace, Joanna Fay, et al.
Cancer Research|April 30, 2017
Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast CancerBo Li, Triona Ni Chonghaile, Yue Fan, et al.
Breast Cancer Research and Treatment|May 13, 2021
The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancerA J Eustace, S F Madden, J Fay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2020
Effects of HER Family-targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast CancerDenis M Collins, Stephen F Madden, Nicola Gaynor, et al.
Cancer Research|March 19, 2014
BRCA1 deficiency exacerbates estrogen-induced DNA damage and genomic instabilityKienan I Savage, Kyle B Matchett, Eliana M Barros, et al.
Biological Psychiatry|May 3, 2011
A quantitative-trait genome-wide association study of alcoholism risk in the community: findings and implicationsAndrew C Heath, John B Whitfield, Nicholas G Martin, et al.
Cancers|March 10, 2022
Functional Antagonism of Junctional Adhesion Molecule-A (JAM-A), Overexpressed in Breast Ductal Carcinoma In Situ (DCIS), Reduces HER2-Positive Tumor ProgressionYvonne E Smith, Guannan Wang, Ciara L Flynn, et al.
Translational Psychiatry|March 23, 2016
Genome-wide polygenic scores for age at onset of alcohol dependence and association with alcohol-related measuresM Kapoor, Y-L Chou, H J Edenberg, et al.
Human Genetics|October 2, 2013
Genetic risk score analysis indicates migraine with and without comorbid depression are genetically different disordersLannie Ligthart, Jouke-Jan Hottenga, Cathryn M Lewis, et al.
Pageof 54

Showing results (451-460 of 536) with videos related to

Sort By:
Pageof 54
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2019
BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast CancerLouise Walsh, Kathryn E Haley, Bruce Moran, et al.
Breast Cancer Research : BCR|July 29, 2017
Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapiesSinead Toomey, Alexander J Eustace, Joanna Fay, et al.
Cancer Research|April 30, 2017
Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast CancerBo Li, Triona Ni Chonghaile, Yue Fan, et al.
Breast Cancer Research and Treatment|May 13, 2021
The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancerA J Eustace, S F Madden, J Fay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2020
Effects of HER Family-targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast CancerDenis M Collins, Stephen F Madden, Nicola Gaynor, et al.
Cancer Research|March 19, 2014
BRCA1 deficiency exacerbates estrogen-induced DNA damage and genomic instabilityKienan I Savage, Kyle B Matchett, Eliana M Barros, et al.
Biological Psychiatry|May 3, 2011
A quantitative-trait genome-wide association study of alcoholism risk in the community: findings and implicationsAndrew C Heath, John B Whitfield, Nicholas G Martin, et al.
Cancers|March 10, 2022
Functional Antagonism of Junctional Adhesion Molecule-A (JAM-A), Overexpressed in Breast Ductal Carcinoma In Situ (DCIS), Reduces HER2-Positive Tumor ProgressionYvonne E Smith, Guannan Wang, Ciara L Flynn, et al.
Translational Psychiatry|March 23, 2016
Genome-wide polygenic scores for age at onset of alcohol dependence and association with alcohol-related measuresM Kapoor, Y-L Chou, H J Edenberg, et al.
Human Genetics|October 2, 2013
Genetic risk score analysis indicates migraine with and without comorbid depression are genetically different disordersLannie Ligthart, Jouke-Jan Hottenga, Cathryn M Lewis, et al.
Pageof 54